Tenderwize
Wróć do wyszukiwania

Open House Discount Agreements for Active Substance Molsidomin

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Mar 31, 2027 · 217 days left·Open·Supplies
Structured notice only
Oryginalny tytuł ogłoszenia

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Molsidomin, ATC C01DX12

75/100

Ocena szansy

PromisingLow complexity
SuppliesOpen
Skąd ta ocena?

Szansa

75 / 100

Złożoność

25 / 100

Czynniki ryzyka

The buyer reserves the right to replace Open House agreements with exclusive contracts from future tenders at any time...

No estimated value is provided. Revenue depends entirely on actual prescriptions and market share. No minimum quantity...

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Strong opportunity

Kluczowe fakty

  • Supplies contract
  • 1 lot
  • Duration until May 2027
  • Conclusion of non-exclusive discount agreements for pharmaceutical products with active substance Molsidomin (ATC C01DX12)
  • Supply of authorized and marketable drugs in Germany
Pokaż pełne podsumowanie

This is an Open House procedure for non-exclusive discount agreements (Rabattverträge) for pharmaceutical products containing the active substance Molsidomin (ATC C01DX12). The contracting authority is AOK Rheinland-Pfalz/Saarland. All interested pharmaceutical companies can join without selection. Contracts run for a maximum of 24 months (from 01.06.2025 to 31.05.2027) and can be terminated with 6 weeks' notice. The Open House may be replaced at any time by exclusive contracts from tendered procedures. Initial submission deadline for the first contract start (01.06.2025) is 30.04.2025; later entries are possible monthly. No estimated contract value is provided. The notice explicitly states that this is not a public procurement under EU law but published voluntarily for transparency.

Ryzyka

The buyer reserves the right to replace Open House agreements with exclusive contracts from future tenders at any time...

No estimated value is provided. Revenue depends entirely on actual prescriptions and market share. No minimum quantity...

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • Proof of marketability via Lauer-Taxe listing or AMIce database extracts

Eligibility

  • Only authorized and marketable drugs in Germany are eligible

Administrative

  • Signed contract documents must be submitted in original (electronic submission not allowed)

Wymagania mogą być niepełne.

Kryteria udzielenia

Lot 1

No award criteria – open house with no selection; all eligible participants are accepted.

Zamawiający

Lokalizacja

Eisenberg, DEU

Profil zamawiającego

Otwórz profil

Identyfikator

DE271900642

Działalność

Health

Części (1)

LOT-0001

Open House Discount Agreements for Active Substance Molsidomin

Non-exclusive discount agreements for Molsidomin (ATC C01DX12) products. All pharmaceutical companies meeting eligibility can join. Contracts run up to 24 months, starting from 01.06.2025. No selection or negotiation; uniform terms for all participants. The buyer may replace these agreements with exclusive contracts from future tenders, leading to automatic termination.

SuppliesEU fundedElectronic submission

Lokalizacja

Eisenberg, Germany

Czas trwania

May 2025 - May 2027

Kategoria

Pharmaceutical products

Kryteria udzielenia

No award criteria – open house with no selection; all eligible participants are accepted.

Termin

Deadline Mar 31, 2027

Szczegóły zamówienia

Data publikacji
10 Apr 2025
Języki
German

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
236173-2025

Dokumenty (1)

Podobne przetargi